Investigation into UK medicines prices to continue
March 24, 2006Competition watchdog the Office of Fair Trading is to continue its investigation into how prescription medicines are priced in the …
Doctors oppose cuts to training budget
March 24, 2006Doctors' leaders have spoken out against cutbacks to the medical training budget, which they warn could seriously harm patient services.The …
Schering backs merger with Bayer
March 24, 2006Sales and Marketing
The management of Schering has unveiled a surprise merger deal with fellow German pharmaceutical company Bayer, in a move designed …
Row over cardiovascular targets in new GP contract
March 24, 2006Research and Development
Patient groups have condemned the new GP contract, saying it ignores a potentially life-threatening condition in tens of thousands of …
Fast growing recruiters thrive on clinical focus
March 23, 2006Business Services
Recruitment company Levy Associates have become one of the UK's fastest growing companies thanks to their success in matching talented …
Roche goes online to co-ordinate recruitment
March 23, 2006Medical Communications
Roche is using a new automated system to identify the best job candidates faster, using online screening developed by technology …
Protelos ‘unique’ among osteoporosis treatments
March 21, 2006Sales and Marketing
Servier says new data on its osteoporosis treatment Protelos shows it reduces women's long-term risk of bone fractures by a …
Whatever happened to e-marketing?
March 17, 2006Sales and Marketing
Is e-marketing dropping off pharma marketing's radar, or are opportunities going begging? Three or four years ago, it was the …
Deal to speed UK uptake of new medicines revealed
March 17, 2006A new deal between the UK government and the pharmaceutical industry to ensure faster and wider access to new medicines …
Investigators to examine Northwick Park trial safety
March 16, 2006Research and Development
Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …
World’s biggest DNA project launched
March 16, 2006Research and Development DNA, MRC, UK Biobank, Wellcome
UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …
Deaths reported in dementia trial
March 16, 2006Research and Development
Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …
Pharma heading for collision course over cancer drug costs
March 16, 2006Sales and Marketing
Fears that the pharmaceutical industry could be on a collision course with Europe's healthcare payers over new high priced medicines …
Making and shaping the headlines
March 15, 2006Medical Communications
Most companies are anxious to court the media to ensure a clearer understanding of their business focus. However, the first …
A place in pharma’s history of innovation
March 15, 2006Sales and Marketing prix galien
Registration has begun for entrants to the 2006 UK Prix Galien, which takes place at the Houses of Parliament this …
New NHS ratings take tougher line on financial performance
March 15, 2006New NHS performance ratings will put equal emphasis on a trust's quality of care and financial management. The independent watchdog, …
Crestor hailed as first drug to reverse cardiovascular disease
March 14, 2006Research and Development
Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …
Schering to fight takeover bid from Merck KGaA
March 14, 2006Sales and Marketing
A hostile takeover bid has been launched by Merck KGaA for rival German pharmaceutical company Schering.Both companies are enjoying strong …
We’re part of the solution, pharma tells Europe
March 13, 2006Sales and Marketing
Europe’s pharmaceutical industry body EFPIA has launched a new promotional campaign for the sector, which it hopes will raise awareness …
NHS chief executive resigns amid financial crisis
March 10, 2006NHS chief executive Nigel Crisp is to step down from the post as debts deepen in the health service.Significant improvements …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
